tradingkey.logo

Movano Inc

MOVE
13.960USD
+0.390+2.87%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.17MMarktkapitalisierung
VerlustKGV TTM

Movano Inc

13.960
+0.390+2.87%

mehr Informationen über Movano Inc Unternehmen

Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.

Movano Inc Informationen

BörsenkürzelMOVE
Name des UnternehmensMovano Inc
IPO-datumMar 23, 2021
CEOMastrototaro (John)
Anzahl der mitarbeiter32
WertpapierartOrdinary Share
GeschäftsjahresendeMar 23
Addresse6800 Koll Center Parkway
StadtPLEASANTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94566
Telefon14156513172
Websitehttps://movanohealth.com/
BörsenkürzelMOVE
IPO-datumMar 23, 2021
CEOMastrototaro (John)

Führungskräfte von Movano Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
56.11K
+54170.00%
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
9.62K
+7748.00%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
6.50K
+5960.00%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
5.96K
+5960.00%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
356.00
--
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Emily Wang Fairbairn
Ms. Emily Wang Fairbairn
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Jill Schmidt
Ms. Jill Schmidt
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. John Mastrototaro, Ph.D.
Dr. John Mastrototaro, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
56.11K
+54170.00%
Mr. Brian Cullinan
Mr. Brian Cullinan
Independent Director
Independent Director
9.62K
+7748.00%
Mr. Ruben Caballero
Mr. Ruben Caballero
Independent Director
Independent Director
6.50K
+5960.00%
Dr. Shaheen Wirk, M.D.
Dr. Shaheen Wirk, M.D.
Independent Director
Independent Director
5.96K
+5960.00%
Mr. Michael Aaron Leabman
Mr. Michael Aaron Leabman
Founder, Chief Technology Officer, Director
Founder, Chief Technology Officer, Director
356.00
--
Mr. Jeremy (J.) Cogan
Mr. Jeremy (J.) Cogan
Chief Financial Officer
Chief Financial Officer
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Mon, Feb 2
Aktualisiert: Mon, Feb 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Appel (Peter A)
7.77%
Cogan (Jeremy D.)
7.77%
Mastrototaro (John)
6.72%
Mairs and Power, Inc.
4.50%
Leabman Holdings LLC
4.50%
Andere
68.75%
Aktionäre
Aktionäre
Anteil
Appel (Peter A)
7.77%
Cogan (Jeremy D.)
7.77%
Mastrototaro (John)
6.72%
Mairs and Power, Inc.
4.50%
Leabman Holdings LLC
4.50%
Andere
68.75%
Aktionärstypen
Aktionäre
Anteil
Individual Investor
30.92%
Investment Advisor
5.11%
Corporation
4.50%
Investment Advisor/Hedge Fund
3.16%
Hedge Fund
0.87%
Research Firm
0.01%
Andere
55.43%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
48
76.39K
9.15%
-71.26K
2025Q3
49
125.47K
15.03%
+1.75K
2025Q2
56
3.25M
46.13%
+457.93K
2025Q1
56
2.83M
40.61%
+410.10K
2024Q4
56
2.31M
34.88%
+869.72K
2024Q3
55
2.03M
30.72%
+612.32K
2024Q2
55
2.06M
31.25%
+706.69K
2024Q1
50
720.48K
20.03%
+1.88K
2023Q4
47
725.57K
20.17%
+32.23K
2023Q3
46
940.36K
29.66%
+64.17K
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Appel (Peter A)
64.88K
7.77%
--
--
Dec 05, 2025
Cogan (Jeremy D.)
5.20K
0.62%
--
--
Dec 05, 2025
Mastrototaro (John)
1.94K
0.23%
--
--
Dec 05, 2025
Mairs and Power, Inc.
37.53K
4.5%
--
--
Sep 30, 2025
Leabman Holdings LLC
37.53K
4.5%
+37.53K
--
Dec 05, 2025
Fairbairn (Malcolm P.)
33.23K
3.98%
-3.52K
-9.59%
Dec 05, 2025
Robert W. Baird & Co. Inc.
20.79K
2.49%
-1.08K
-4.95%
Sep 30, 2025
Fairbairn Emily Wang
6.21K
0.74%
+4.30K
+225.07%
Dec 05, 2025
Cullinan (Brian)
1.87K
0.22%
--
--
Dec 05, 2025
Caballero (Ruben)
535.00
0.06%
--
--
Dec 05, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
Anteil0%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Oct 08, 2025
Merger
10→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Datum
Ex-Dividendentag
Art
Verhältnis
Oct 08, 2025
Merger
10→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
Oct 25, 2024
Merger
15→1
KeyAI